Despite this variability, results clearly showed the high production of IFN-γ in Tri-T cells, suggesting that Tri-T cells can be generated in large quantities by using antigen combinations and may be beneficial to AML treatment. The gene discussed is IFNG; the disease is acute myeloid leukemia.